Please select the outcome measures that correspond to the clinical trial below.
Title: Optimizing Veteran-Centered Prostate Cancer Survivorship Care
Brief Summary: This study will provide much needed information about how to optimize the quality of care and quality of life of Veterans who are survivors of prostate cancer.


Options:
A: The Expanded Prostate Cancer Index (EPIC) - Urinary Health, Irritative (Baseline); The Expanded Prostate Cancer Index (EPIC) - Urinary Health, Obstructive (Baseline); The Expanded Prostate Cancer Index (EPIC) - Bowel Health (Baseline); The Expanded Prostate Cancer Index (EPIC) - Sexual Health (Baseline); The Expanded Prostate Cancer Index (EPIC) - General Health (Baseline); The Expanded Prostate Cancer Index (EPIC) - EPIC-26 Mean (Baseline); The Expanded Prostate Cancer Index (EPIC) - Urinary Health, Irritative (5 Months); The Expanded Prostate Cancer Index (EPIC) - Urinary Health, Obstructive (5 Months); The Expanded Prostate Cancer Index (EPIC) - Bowel Health (5 Months); The Expanded Prostate Cancer Index (EPIC) - Sexual Health (5 Months); The Expanded Prostate Cancer Index (EPIC) - General Health (5 Months); The Expanded Prostate Cancer Index (EPIC) - Urinary Health, Irritative (12 Months); The Expanded Prostate Cancer Index (EPIC) - Urinary Health, Obstructive (12 Months); The Expanded Prostate Cancer Index (EPIC) - Bowel Health (12 Months); The Expanded Prostate Cancer Index (EPIC) - Sexual Health (12 Months); The Expanded Prostate Cancer Index (EPIC) - General Health (12 Months); Confidence in Symptom Self-Management (5 months); Confidence in Symptom Self-Management (12 months)
B: Patients' score on the EORTC-INFO26 module15 questionnaire, measuring ´Satisfaction with information provision´, right after initial treatment (Right after initial treatment (t0)); Patients' score on the EORTC QLQ-C3017 questionnaire, measuring ´Health related quality of life (HRQL)´, right after initial treatment (Right after initial treatment (t0)); Patients' score on the EORTC IN-PATSAT3216 questionnaire, measuring ´Satisfaction with care´, right after initial treatment (Right after initial treatment (t0)); Patients' score on the Brief Illness Perception Questionnaire (B-IPQ)21, measuring ´Illness perception´, right after initial treatment (Right after initial treatment (t0)); Patients' score on the EORTC-INFO26 module15 questionnaire, measuring ´Satisfaction with information provision´, 6 months after initial treatment (6 months after initial treatment (t1)); Patients' score on the EORTC QLQ-C3017 questionnaire, measuring ´Health related quality of life (HRQL)´, 6 months after initial treatment (6 months after initial treatment (t1)); Patients' score on the EORTC IN-PATSAT3216 questionnaire, measuring ´Satisfaction with care´, 6 months after initial treatment (6 months after initial treatment (t1)); Patients' score on the Brief Illness Perception Questionnaire (B-IPQ)21, measuring ´Illness perception´, 6 months after initial treatment (6 months after initial treatment (t1)); Patients' score on the EORTC-INFO26 module15 questionnaire, measuring ´Satisfaction with information provision´, 12 months after initial treatment (12 months after initial treatment (t2)); Patients' score on the EORTC QLQ-C3017 questionnaire, measuring ´Health related quality of life (HRQL)´, 12 months after initial treatment (12 months after initial treatment (t2)); Patients' score on the EORTC IN-PATSAT3216 questionnaire, measuring ´Satisfaction with care´, 12 months after initial treatment (12 months after initial treatment (t2)); Patients' score on the Brief Illness Perception Questionnaire (B-IPQ)21, measuring ´Illness perception´, 12 months after initial treatment (12 months after initial treatment (t2)); Patients' score on the EORTC-INFO26 module15 questionnaire, measuring ´Satisfaction with information provision´, 18 months after initial treatment (18 months after initial treatment (t3)); Patients' score on the EORTC QLQ-C3017 questionnaire, measuring ´Health related quality of life (HRQL)´, 18 months after initial treatment (18 months after initial treatment (t3)); Patients' score on the EORTC IN-PATSAT3216 questionnaire, measuring ´Satisfaction with care´, 18 months after initial treatment (18 months after initial treatment (t3)); Patients' score on the Brief Illness Perception Questionnaire (B-IPQ)21, measuring ´Illness perception´, 18 months after initial treatment (18 months after initial treatment (t3)); Patients' score on the EORTC-INFO26 module15 questionnaire, measuring ´Satisfaction with information provision´, 24 months after initial treatment (24 months after initial treatment (t4)); Patients' score on the EORTC QLQ-C3017 questionnaire, measuring ´Health related quality of life (HRQL)´, 24 months after initial treatment (24 months after initial treatment (t4)); Patients' score on the EORTC IN-PATSAT3216 questionnaire, measuring ´Satisfaction with care´, 24 months after initial treatment (24 months after initial treatment (t4)); Patients' score on the Brief Illness Perception Questionnaire (B-IPQ)21, measuring ´Illness perception´, 24 months after initial treatment (24 months after initial treatment (t4))
C: Change in FACIT-TS questionnaire score (Baseline, 6 months)
D: Subscale quality of life of the questionnaire: EORTC QLQ C30 (After each treatment completion, during follow up; first year every 3 months, second year every 6 months)

Answer: A